v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (2,459,800) $ (3,286,022)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,174,074 1,177,270
Share-based compensation expense 55,170
Stock issued for special stock bonus 862,230
Changes in operating assets and liabilities:    
Accounts receivable (1) (35)
Inventory (27,539) 1,925
Other current assets 61,582 20,293
Accrued expenses and other current and long-term liabilities 268,263 (55,409)
Net cash used in operating activities (983,421) (1,224,578)
Cash flows from investing activities:    
Purchase of property and equipment (8,542) (33,640)
Proceeds from disposal of equipment 1,750
Decrease in refundable deposits and other assets 6,713 13,053
Net cash used in investing activities (79) (20,587)
Cash flows from financing activities:    
Proceeds from Loan agreement 2,812,940
Proceeds from at-the-market offering, net of issuance costs 601,600 14,605
Net cash provided by financing activities 3,414,540 14,605
Effect from foreign currency exchange (6,971) (34,073)
Net (decrease) increase in cash and cash equivalents 2,424,069 (1,264,633)
Cash and cash equivalents at beginning of period 417,353 3,892,919
Cash and cash equivalents at end of period $ 2,841,422 $ 2,628,286